Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia: Systematic Overview and Quality Appraisal of the Meta-analytic Evidence

Psychosis and Schizophrenia

Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses

Lancet Psychiatry.

Zhu Y, Krause M, Huhn M, Rothe P, Schneider-Thoma J, Chaimani A, Li C, Davis JM, Leucht S

doi: 10.1016/S2215-

Psychosis and Schizophrenia

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies

Lancet Psychiatry

Kishimoto T, Hagi K, Kurokawa S, Kane JM, Correll CU

doi: 10.1016/S2215-0366(21)00039-0

Bipolar Disorder

Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis

J Affect Disord.

Bahji A, Ermacora D, Stephenson C, Hawken ER, Vazquez G

doi: 10.1016/j.jad.2020.03.030.

Psychosis and Schizophrenia

Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis

Acta Psychiatr Scand.

Okhuijsen-Pfeifer C, Huijsman EAH, Hasan A, Sommer IEC, Leucht S, Kahn RS, Luykx JJ

doi: 10.1111/acps.12954.

DementiaPsychosis and Schizophrenia

Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials

Lancet Psychiatry.

Schneider-Thoma J, Efthimiou O, Huhn M, Krause M, Reichelt L, Röder H, Davis JM, Salanti G, Leucht S

doi: 10.1016/S2215-

Psychosis and Schizophrenia

Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study

Lancet Psychiatry.

Gründer G, Heinze M, Cordes J, Mühlbauer B, Juckel G, Schulz C, Rüther E, Timm J; NeSSy Study Group

doi: 10.1016/

Bipolar Disorder

Maintenance therapy with second generation antipsychotics for bipolar disorder - A systematic review and meta-analysis

J Affect Disord.

Lindström L, Lindström E, Nilsson M, Höistad M

doi: 10.1016/j.jad.2017.02.012.

Psychosis and Schizophrenia

Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials

Lancet Psychiatry

Højlund M, Kemp AF, Haddad PM, Neill JC, Correll CU

doi: 10.1016/S2215-0366(21)00078-X

Psychosis and Schizophrenia

Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia

JAMA Psychiatry.

Tiihonen J, Taipale H, Mehtälä J, Vattulainen P, Correll CU, Tanskanen A

doi: 10.1001/jamapsychiatry.

Related content

Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies

Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis

Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis

Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials

Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study

Maintenance therapy with second generation antipsychotics for bipolar disorder - A systematic review and meta-analysis

Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials

Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia